Physician

Charles E. Greeson, M.D.

According to 2025 Medicare claims, Charles Greeson, M.D. (NPI: 1003919994) practices dermatology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is SHANNON CLINIC (NPI: 1770587149; TIN: 752600873) and primary practice location at 76904-6884.

Greeson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,183 traditional Medicare patients, billed 4,119 HCPCS/CPT codes, and received $236,310 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,272 prescription claims across 471 beneficiaries totaling $1,566,379 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 22 records totaling $531. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $59,857 to $1,566,379. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$123K$247K2015 Medicare payment: $137,094 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $187,210 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $220,240 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $237,285 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $246,668 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $205,116 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $210,505 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $209,643 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $212,858 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $236,310 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157513,421$137,094
20168534,628$187,210
20171,0405,277$220,240
20181,1865,345$237,285
20191,3054,854$246,668
20201,2093,955$205,116
20211,0973,797$210,505
20221,1014,074$209,643
20231,1103,900$212,858
20241,1834,119$236,310

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$783K$1.6M2015 Drug cost: $59,857 (USD; Tot_Drug_Cst)2016 Drug cost: $188,138 (USD; Tot_Drug_Cst)2017 Drug cost: $225,592 (USD; Tot_Drug_Cst)2018 Drug cost: $253,079 (USD; Tot_Drug_Cst)2019 Drug cost: $402,546 (USD; Tot_Drug_Cst)2020 Drug cost: $536,699 (USD; Tot_Drug_Cst)2021 Drug cost: $682,097 (USD; Tot_Drug_Cst)2022 Drug cost: $807,954 (USD; Tot_Drug_Cst)2023 Drug cost: $1,140,468 (USD; Tot_Drug_Cst)2024 Drug cost: $1,566,379 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015214436$59,857
2016227544$188,138
2017307742$225,592
2018340871$253,079
20194201,107$402,546
20204371,239$536,699
20214441,193$682,097
20224151,100$807,954
20234301,196$1,140,468
20244711,272$1,566,379

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth314356$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more722929$65
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more226242$39
17000Destruction of precancer skin growth, 1 growth473559$36
17003Destruction of precancer skin growth, 2-14 growths280733$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab29812$235,562
Cosentyx Unoready PenSecukinumab26728$216,477
Dupixent PenDupilumab421,456$182,797
Enbrel MiniEtanercept15420$130,135
Enbrel SureclickEtanercept15420$113,921

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$531Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles E. Greeson, M.D.?

Tedicare shows public-source Medicare data for Charles E. Greeson, M.D. (NPI 1003919994), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles E. Greeson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles E. Greeson, M.D.?

Charles E. Greeson, M.D. is linked to SHANNON CLINIC (billing NPI 1770587149) in the available physician profile data.

Does Charles E. Greeson, M.D. have Open Payments data?

Charles E. Greeson, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.